Home > Financial Ratios > SUN PHARMA ADVANCED RESEARCH COMPANY

SUN PHARMA ADVANCED RESEARCH COMPANY
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SUN PHARMA ADVANCED RESEARCH COMPANY
Please provide your vote to see the results

SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year EV/Core EBITDA History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) -31.79-28.11-45.27-30.37-8.64

What is the latest EV/Core EBITDA ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?

The latest EV/Core EBITDA ratio of SUN PHARMA ADVANCED RESEARCH COMPANY is -31.79 based on Mar2024 Standalone results.
Year EV/Core EBITDA
Mar2024-31.79
Mar2023-28.11
Mar2022-45.27
Mar2021-30.37
Mar2020-8.64

How is EV/Core EBITDA of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?

Years EV/Core EBITDA % Change
Mar2024 -31.79
Negative
Mar2023 -28.11
Negative
Mar2022 -45.27
Negative
Mar2021 -30.37
Negative
Mar2020 -8.64 -

Other Financial Ratios of SUN PHARMA ADVANCED RESEARCH COMPANY


Compare EV/Core EBITDA ratio of peers of SUN PHARMA ADVANCED RESEARCH COMPANY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY ₹7,007.6 Cr 5% NA -6.6% Stock Analytics
SYNGENE INTERNATIONAL ₹34,612.1 Cr -1.7% -5.5% 25.6% Stock Analytics
JUST DIAL ₹9,655.9 Cr 5.3% -2.5% 50.3% Stock Analytics
LATENT VIEW ANALYTICS ₹9,436.8 Cr 2.9% -3.7% 9.2% Stock Analytics
DREAMFOLKS SERVICES ₹2,414.6 Cr 5.1% -2.1% -6.8% Stock Analytics
EKI ENERGY SERVICES ₹798.9 Cr -3% -6% -31.1% Stock Analytics


SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUN PHARMA ADVANCED RESEARCH COMPANY

5%

NA

-6.6%

SENSEX

-0.8%

-5.8%

24.5%


You may also like the below Video Courses